Author

Bruce E. Sands 1

1 Icahn School of Medicine at Mt Sinai, New York, United States of America

A POOLED SAFETY ANALYSIS FROM THE USTEKINUMAB CROHN?S DISEASE AND PSORIATIC DISEASES PHASE 2 AND 3 CLINICAL TRIAL PROGRAMS

Subrata Ghosh, Bruce E. Sands, Willem de Villiers, Elyssa Ott, Christopher Gasink, Yinghua Lang, Philippe Szapary, Douglas Jacobstein, Brian G. Feagan

A RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY TO EXPLORE THE EFFICACY OF ORAL GED-0301 (MONGERSEN) ON ENDOSCOPIC ACTIVITY AND CLINICAL EFFECTS IN BOTH TNF-NAIVE AND TNF-EXPERIENCED SUBJECTS WITH ACTIVE CROHN?S DISEASE

Brian G. Feagan, Bruce E. Sands, Guillermo Rossiter, Xiaobin Li, Keith Usiskin, Xiaojiang Zhan, Jean-Frederic Colombel

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH IMPROVEMENTS IN CLINICAL OUTCOMES IN PATIENTS WITH ULCERATIVE COLITIS RECEIVING MIRIKIZUMAB

Marla C. Dubinsky, Remo Panaccione, James D Lewis, Bruce E. Sands, Toshifumi Hibi, Scott D. Lee, April Naegeli, Mingyang Shan, Linden Green, Nathan Morris, Vipin Arora, Alison Potts Bleakman, Ruth Belin, Simon Travis

ABSENCE OF BOWEL URGENCY IS ASSOCIATED WITH SIGNIFICANTLY IMPROVED INFLAMMATORY BOWEL DISEASE RELATED QUALITY OF LIFE IN A PHASE 2 TRIAL OF MIRIKIZUMAB IN PATIENTS WITH ULCERATIVE COLITIS

Marla C. Dubinsky, Scott D. Lee, Remo Panaccione, Maria T. Abreu, Severine Vermeire, Trevor Lissoos, Nathan Morris, Vipin Arora, Mingyang Shan, April Naegeli, Bruce E. Sands

AN UPDATE ON THE ANALYSIS OF NON-MELANOMA SKIN CANCER IN THE TOFACITINIB ULCERATIVE COLITIS CLINICAL PROGRAMME AS OF MAY 2019

Bruce E. Sands, Walter Reinisch, Julian Panés, Paulo Gustavo Kotze, Donna T Judd, Rajiv Mundayat, Nervin Lawendy

An update on the analysis of non-melanoma skin cancer in the tofacitinib ulcerative colitis programme

Bruce E. Sands, Millie D. Long, Leonard Baidoo, Walter Reinisch, Julian Panés, Arif Soonasra, Ronald D. Pedersen, Nervin Lawendy, Gary Chan

ANALYSIS OF NON-MELANOMA SKIN CANCER IN THE ULCERATIVE COLITIS PROGRAMME FOR TOFACITINIB

Bruce E. Sands, Millie D. Long, Leonard Baidoo, Walter Reinisch, Julian Panés, Chudy I. Nduaka, Arif Soonasra, Ronald D. Pedersen, Nervin Lawendy, Gary Chan, Gary S. Friedman, Chinyu Su

Association of Ustekinumab Serum Concentrations and Perianal Fistula Resolution in the Crohn's Disease UNITI Program

Bruce E. Sands, Brian Kramer, Christopher Gasink, Douglas Jacobstein, Long-Long Gao, Tony Ma, Omoniyi J. Adedokun, Jean-Frederic Colombel, David A Schwartz

ASSOCIATION OF USTEKINUMAB SERUM CONCENTRATIONS AND PERIANAL FISTULA RESOLUTION IN THE CROHN'S DISEASE UNITI PROGRAM

Bruce E. Sands

Corticosteroid Sparing Effects of Ustekinumab Therapy in Ulcerative Colitis Patients: Results From the UNIFI Program

Silvio Danese, Bruce E. Sands, Laurent Peyrin-Biroulet, C Marano, Christopher O’Brien, Hongyan Zhang, Alessandra Nunes Faria Oortwijn, David Rowbotham, Rupert W Leong, Ramesh P. Arasaradnam, Gert Van Assche, William Sandborn, Remo Panaccione

Item 1 - 10 / 60
1
2 3 4 5 6